These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37806093)

  • 1. Effect of caper fruit (Capparis spinosa L.) consumption on liver enzymes, lipid profile, fasting plasma glucose, and weight loss. A systematic review and a preliminary meta-analysis of randomized controlled trials.
    Perna S; Rafique A; Rondanelli M; Allehdan S; Riso P; Marino M
    Biomed Pharmacother; 2023 Dec; 168():115638. PubMed ID: 37806093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Capparis spinosa Extract on Metabolic Parameters in Patients with Type-2 Diabetes: A Randomized Controlled Trial.
    Vahid H; Bonakdaran S; Khorasani ZM; Jarahi L; Rakhshandeh H; Ghorbani A; Zarghi N; Yousefi M
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):100-107. PubMed ID: 30657033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.
    Huseini HF; Hasani-Rnjbar S; Nayebi N; Heshmat R; Sigaroodi FK; Ahvazi M; Alaei BA; Kianbakht S
    Complement Ther Med; 2013 Oct; 21(5):447-52. PubMed ID: 24050578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Daily Caper Fruit Pickle Consumption on Disease Regression in Patients with Non-Alcoholic Fatty Liver Disease: a Double-Blinded Randomized Clinical Trial.
    Khavasi N; Somi MH; Khadem E; Faramarzi E; Ayati MH; Fazljou SMB; Torbati M
    Adv Pharm Bull; 2017 Dec; 7(4):645-650. PubMed ID: 29399555
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Del Bo' C; Perna S; Allehdan S; Rafique A; Saad S; AlGhareeb F; Rondanelli M; Tayyem RF; Marino M; Martini D; Riso P
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF; Wang C; Yang T; Li S; Li KL; Li D
    Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.
    Akbari M; Tamtaji OR; Lankarani KB; Tabrizi R; Dadgostar E; Haghighat N; Kolahdooz F; Ghaderi A; Mansournia MA; Asemi Z
    Lipids Health Dis; 2020 Feb; 19(1):25. PubMed ID: 32066446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
    Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
    [No Abstract]   [Full Text] [Related]  

  • 16. Sumac fruit supplementation improve glycemic parameters in patients with metabolic syndrome and related disorders: A systematic review and meta-analysis.
    Ghafouri A; Estêvão MD; Alibakhshi P; Pizarro AB; Kashani AF; Persad E; Heydari H; Hasani M; Heshmati J; Morvaridzadeh M
    Phytomedicine; 2021 Sep; 90():153661. PubMed ID: 34334274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis.
    Allen RW; Schwartzman E; Baker WL; Coleman CI; Phung OJ
    Ann Fam Med; 2013; 11(5):452-9. PubMed ID: 24019277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of walnut consumption on cardio metabolic and anthropometric parameters in metabolic syndrome patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials.
    Arabi SM; Bahrami LS; Milkarizi N; Nematy M; Kalmykov V; Sahebkar A
    Pharmacol Res; 2022 Apr; 178():106190. PubMed ID: 35338001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis.
    Rezaei S; Tabrizi R; Nowrouzi-Sohrabi P; Jalali M; Atkin SL; Al-Rasadi K; Jamialahmadi T; Sahebkar A
    Can J Gastroenterol Hepatol; 2021; 2021():8936865. PubMed ID: 34805029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Lee D; Chiavaroli L; Ayoub-Charette S; Khan TA; Zurbau A; Au-Yeung F; Cheung A; Liu Q; Qi X; Ahmed A; Choo VL; Blanco Mejia S; Malik VS; El-Sohemy A; de Souza RJ; Wolever TMS; Leiter LA; Kendall CWC; Jenkins DJA; Sievenpiper JL
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.